Friedmann, Zoe
Kinkel, Hans-Tilmann
Kühner, Claudia
Zsolnai, Andreas
Mick, Inge
Binder, Annette
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
Article History
Received: 11 May 2023
Accepted: 24 October 2023
First Online: 1 November 2023
Declarations
:
: We obtained approval from the ethics committee of Landesärztekammer Baden-Württemberg (file number F-2022-002). All participants gave their informed written and verbal consent to participate in the study. We can provide additional information on our application and approval upon request.
: All participants gave their informed written and oral consent to have their anonymised data published.
: ZF: Financial and non-monetary stipend from Studienstiftung des Deutschen Volkes (scholarship program from the German government). HK: Medical head and director of an outpatient clinic for addiction medicine (Praxiskombinat Neubau Berlin); Speaker's fees from Accente BizzComm GmbH, AbbVie Deutschland GmbH & Co. KG, and GILEAD Sciences GmbH; conference travel and attendance fees from GILEAD Sciences GmbH. CK: Psychologist at an outpatient clinic for addiction medicine (Schwerpunktpraxis für Suchtmedizin Stuttgart). AZ: Medical head and director of an outpatient clinic for addiction medicine (Schwerpunktpraxis für Suchtmedizin Stuttgart). IM: Senior physician in general adult psychiatry (including care for addictive behaviours) at Charité Berlin. AB: Member of Deutsche Gesellschaft für Suchtforschung und Suchttherapie e.V. (German society of addiction research and addiction therapy); medical residency in addiction medicine at Medical University Hospital Tuebingen.